SIGA Technologies Inc

NASDAQ SIGA

Data sourced from iex and EODHD
Download Data

SIGA Technologies Inc Free Cash Flow for the quarter ending March 31, 2024: USD -6.12 M

SIGA Technologies Inc Free Cash Flow is USD -6.12 M for the quarter ending March 31, 2024, a -125.03% change year over year. Free Cash Flow is the cash flow available to a company after deducting capital expenditures from operating cash flow, indicating its ability to generate cash for expansion, debt repayment, or dividends.
  • SIGA Technologies Inc Free Cash Flow for the quarter ending March 31, 2023 was USD 24.45 M, a -56.89% change year over year.
  • SIGA Technologies Inc Free Cash Flow for the quarter ending March 31, 2022 was USD 56.71 M, a 1,276.47% change year over year.
  • SIGA Technologies Inc Free Cash Flow for the quarter ending March 31, 2021 was USD -4.82 M, a -245.75% change year over year.
  • SIGA Technologies Inc Free Cash Flow for the quarter ending March 31, 2020 was USD 3.31 M, a 772,550.93% change year over year.
NASDAQ: SIGA

SIGA Technologies Inc

CEO Dr. Phillip Louis Gomez III, M.D., Ph.D.
IPO Date Sept. 9, 1997
Location United States
Headquarters 31 East 62nd Street, New York, NY, United States, 10065
Employees 45
Sector Healthcare
Industry Drug manufacturers - specialty & generic
Description

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

Similar companies

CTLT

Catalent Inc

NA

NA

PAHC

Phibro Animal Health Corporation

NA

NA

StockViz Staff

September 20, 2024

Any question? Send us an email